Skip to content

Batch information on every product pageTHC < 0.3%Shipped from France10% off when you sign up

CBN-C1Cannabiorcol

The methyl (C1) homologue of cannabinol, tentatively reported in hashish, with no measured pharmacology.

Level of detail

Harm-reduction warning

No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.

C₁₇H₁₈O₂

CAS 19825-73-1

Family
PhytocannabinoidMinor
Origin
Tentative identification
Molar mass
254.32 g/mol

Updated on

In plain terms

Cannabiorcol is a close relative of CBN whose side chain has only one carbon atom instead of five. It was reported in hashish in 1972, by an identification that remains tentative. What it does in the body has not been measured.

Receptors and activity

    Bar length follows the measured value (Ki, Kd, EC50 or IC50), on one scale shared by every entry, from 100 µM to 0.1 nM. A target with no cited value has no bar.

    Pharmacology

    Cannabiorcol (CBN-C1) is the methyl-chain homologue of cannabinol: the same fully aromatised benzo[c]chromene skeleton, with no stereocentre, but a single side-chain carbon instead of five. Vree and colleagues reported it in 1972 in hashish, together with the methylated analogues of tetrahydrocannabinol and cannabidiol, by gas chromatography coupled with mass spectrometry; this identification remains tentative, with no isolation and no reference standard. If present, it would form like cannabinol by oxidation of its tetrahydro precursor, which has not been studied. No affinity constant for CB1 or CB2, no screen at other targets and no pharmacokinetic, metabolism or toxicology data were found. The only reference point is indirect: in the THC series, binding to the CB1 receptor requires a side chain of at least 3 carbons, the optimum lying between 5 and 8 (Bow and Rimoldi 2016). In France, its structure falls within the generic class of benzo[c]chromene derivatives created by the ANSM in 2024, from which only CBN and CBNA are excluded by name.

    History

    Source
    Cannabis sativa L.: tentative identification only, by gas chromatography coupled with mass spectrometry in hashish (Vree et al. 1972), without isolation or confirmation against a reference standard. If it is indeed present, it would form like cannabinol, an oxidation product of Δ9-THC, from tetrahydrocannabiorcol; this lineage has not been studied. Origin not established.

    Biosynthetic pathway

    No formation pathway has been demonstrated for cannabiorcol. By analogy with cannabinol, which results from the oxidation of Δ9-THC and not from a plant enzyme, formation by aromatising oxidation of tetrahydrocannabiorcol is plausible, but no study has established it.

    Classification

    Family, origin and source verification

    Family

    Phytocannabinoid › Minor

    Presence in the plant

    Tentative identification, never isolated

    Chemistry

    Type CBN · C1 side chain · neutral form

    Verification

    Checked on 20 October 2026; some points still await human review.

    Wikipedia (English)

    No dedicated article.

    References

    Identifiers

    Names

    Common name
    Cannabiorcol
    IUPAC name
    3,6,6,9-tetramethylbenzo[c]chromen-1-ol
    Other names
    cannabinol-C1

    Identifiers

    Formula
    C₁₇H₁₈O₂
    CAS
    19825-73-1
    InChIKey
    XWIWWMIPMYDFOV-UHFFFAOYSA-N
    SMILES
    CC1=CC2=C(C=C1)C(OC3=CC(=CC(=C32)O)C)(C)C

    Machine-readable entry (JSON)

    LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.